Interactions Between Cocaine and Ethanol and Disulfiram - 1

Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Unknown status
CT.gov ID
NCT00094289
Collaborator
(none)
16
2
11
8
0.7

Study Details

Study Description

Brief Summary

The purpose of this study is to assess potential interactions between intravenous cocaine and ethanol and oral disulfiram.

Condition or Disease Intervention/Treatment Phase
Phase 1

Detailed Description

This is a two-site, double blind, placebo-controlled inpatient study to determine the cardiovascular and psychiatric safety of alcohol use in cocaine-dependent subjects who had used cocaine after treatment with disulfiram.

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Interactions Between IV Cocaine and Ethanol and Oral Disulfiram
Study Start Date :
Aug 1, 2004
Study Completion Date :
Jul 1, 2005

Outcome Measures

Primary Outcome Measures

  1. Safety assessments []

  2. Psychological effects []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must meet DSM-4 criteria for cocaine abuse or dependence and are not seeking treatment.

  • Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements.

Exclusion Criteria:
  • Please contact site for more information.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCLA Integrated Substance Abuse Program Los Angeles California United States 90024
2 University of Texas Hlth Sci Ctr San Ant San Antonio Texas United States 78284 7828

Sponsors and Collaborators

  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: John Roache, Ph.D., University of Texas Health Sci Cntr, San Antonio

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00094289
Other Study ID Numbers:
  • NIDA-MDS-0003-1
First Posted:
Oct 15, 2004
Last Update Posted:
Jan 11, 2017
Last Verified:
Jul 1, 2005

Study Results

No Results Posted as of Jan 11, 2017